Vizient, Fresenius Kabi to supply 6 critical care drugs

Vizient signed an agreement Nov. 21 with German drugmaker Fresenius Kabi to supply six critical care drugs through its Novaplus pharmacy program. 

The six drugs include propofol, an anesthesia drug manufactured by Fresenius Kabi that is sold as Diprivan. The other drugs are protamine, phenylephrine, oxytocin, thiamine and magnesium sulfate. 

The drugs are the first critical care drugs added to Novaplus, a program intended to offset drug shortages by better anticipating demand. 

Read the full news release here

More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months